Abstract: The invention relates to novel tetrahydroquinoline compounds having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of various CNS disorders.
Type:
Grant
Filed:
November 16, 2001
Date of Patent:
February 1, 2005
Assignee:
SmithKline Beecham p.l.c.
Inventors:
Steven Mark Bromidge, Stephen Frederick Moss